All Articles tagged Inc. v. U.S. Int'l Trade Comm'n

• General
  January 01, 2010 EDT
  A SAFE HARBOR FOR DRUGS MADE OFFSHORE: THE FEDERAL CIRCUIT RENDERS THE BOLAR AMENDMENT AVAILABLE IN § 337 ACTIONS IN AMGEN V. U.S. INTERNATIONAL TRADE COMMISSION
  Teige P Sheehan

  This comment articulates the current state of patent law as it pertains to importation and the pharmaceutical industry, in light of Amgen, Inc. v. U.S. Int'l Trade Comm'n.